PrimeRFP SCOUT · Federal Contract Recompete Brief

W81K0025PA278Radiopharmaceuticals- WBAMC — Curium Us LLC

Curium Us LLC holds $1.8M across 17 federal awards, concentrated at Department of Defense (DOD). This PIID sits alongside 1 related award in the incumbent pipeline. The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. Recompete timing centers on the Sep 30, 2026 PoP end — agencies typically plan 12–18 months ahead.

W40m Mrc0 West
Awarding office
Curium Us LLC
Recipient
Sep 30, 2026
PoP end
$251K
Obligated
$251K
Potential
325412
NAICS
6505
PSC
NONE
Set-aside
1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Curium Us LLC — $90

Contract facts

NONE
Contract numberW81K0025PA278
AgencyW40m Mrc0 West
Awarding officeW40m Mrc0 West
Awarding agencyDepartment of Defense (DOD)
Funding agencyDepartment of Defense (DOD)
IncumbentCurium Us LLC
CAGE7MFS7
UEICFJJPP5KQNX9
NAICS325412

No full NAICS 325412 intel page yet. Browse NAICS intelligence

PSC6505
Place of performanceFORT BLISS TX
Pricing typeFirm Fixed Price
Extent competedNot Competed Under SAP
PoP startOct 1, 2025
PoP end (current)Sep 30, 2026
Obligated$251K
Current value$251K
Potential value$251K

RADIOPHARMACEUTICALS- WBAMC. is a federal NONE award for W40m Mrc0 West held by Curium Us LLC. Estimated value $251K ($251K obligated). Current period of performance ends Sep 30, 2026. Last award drew 1 bidder. Place of performance: FORT BLISS TX.

Recompete timing

Public
Expiring in 40 days

Current PoP ends Sep 30, 2026 (40 days remaining). Agencies typically plan 12–18 months ahead — at 1.3 months out, that window is already open. The buying decision is likely already in motion.

Incumbent footprint

Public record

Curium Us LLC$1.8M obligated across 17 awards (firm-wide, all agencies) · lead buyer Department of Defense (DOD).

% of firm-wide obligated ($1.8M) · all agencies
Department of Defense (DOD)$1.6M · 89%Department of Veterans Affairs (VA)$206K · 11%
Open full company profile

Related awards

Same incumbent
36C26326N0164
FY26 DELIVERY ORDER
$162K
Sep 30, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract W81K0025PA278?

W81K0025PA278 (Radiopharmaceuticals- WBAMC) is a W40m Mrc0 West award with a potential value of $251K, currently held by Curium Us LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded W81K0025PA278?

W40m Mrc0 West awarded W81K0025PA278 to Curium Us LLC (potential $251K).

Who is the incumbent on W81K0025PA278?

Curium Us LLC is the incumbent with $1.8M across 17 related awards in SCOUT’s public footprint. The current period of performance ends Sep 30, 2026.

When does Curium Us LLC’s W81K0025PA278 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 30, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/W81K0025PA278